NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-28 19:31இன்று 333 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Sadhana Nitro Chem Q2 Revenue Jumps to ₹35.67 Cr; Swings to Net Profit of ₹0.85 Cr
Sadhana Nitrochem reported standalone Q2 FY27 revenue from operations of ₹35.67 Cr, a steep jump compared to ₹0.26 Cr in Q2 FY26. The company turned profitable at the standalone net level, posting a PAT of ₹0.85 Cr versus a net loss of ₹26.38 Cr in the corresponding prior-year quarter. For H1 FY27, total operational revenue stood at ₹61.85 Cr with a net profit of ₹0.45 Cr. Additionally, the company raised ₹13.91 Cr in August 2026 via a preferential allotment of 6.75 crore equity shares.
உச்சம் நம்பிக்கை
என்ன மாறியதுSadhana Nitro Chem transitioned from steep operating losses to positive standalone net profitability in Q2.
ஏன் இது முக்கியம்The company had posted a net loss of ₹86.81 Cr in FY26; achieving operational profitability and scaling quarterly revenue above ₹35 Cr points to a nascent operational turnaround.
📅 குறுகிய காலம்The return to positive operating profits and net PAT after heavy multi-quarter losses is likely to be viewed constructively in the near term.
📈 நீண்ட காலம்Sustained turnaround depends on plant utilization, pricing discipline against low-cost Chinese imports, and containing working capital borrowings.
⚠ அபாய எச்சரிக்கைகள்
History of intense competition and dumping from Chinese producers affecting margins
Significant bank overdraft/cash credit balances of ₹51.20 Cr impacting liquidity
👀 கவனிக்க வேண்டியவை
Track whether revenue momentum and operational profitability persist in Q3, and monitor operational ramp-up across key products like PAP and ODB2.
Sadhana Nitrochem CFO Vimal Rameshchandra Jain Resigns with Immediate Effect
Sadhana Nitrochem announced that Mr. Vimal Rameshchandra Jain has resigned from his role as Chief Financial Officer (CFO) and President - Operations & Finance, effective October 13, 2026. The resignation is cited as being due to personal reasons. The exit occurs against a backdrop of financial stress, with the company reporting a TTM net loss of Rs 85 crore and an operating margin of -108.6%. The company has not yet announced a successor for the key managerial role.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. Vimal Rameshchandra Jain stepped down from his executive positions as CFO and President - Operations & Finance on October 13, 2026.
ஏன் இது முக்கியம்Abrupt departure of a key managerial personnel heading both finance and operations adds governance uncertainty, especially when the company is navigating severe operating losses.
Cessation Date: அக்டோபர் 13, 2026Debt vs Market Cap: ~90.4%TTM Net Loss: Rs -85 Cr
📅 குறுகிய காலம்May weigh on investor sentiment due to leadership discontinuity in critical financial and operational roles.
📈 நீண்ட காலம்Limited long-term impact once a credible replacement is appointed, though execution and turnaround in operational margins remain primary concerns.
⚠ அபாய எச்சரிக்கைகள்
Key managerial turnover during period of severe financial distress
Successor not named simultaneously
👀 கவனிக்க வேண்டியவை
Track the announcement of an interim or permanent CFO appointment and observe whether financial reporting timelines and audit disclosures remain stable in upcoming quarterly filings.
Sadhana Nitrochem has approved the allotment of 6.75 crore equity shares on a preferential basis at a price of Rs 2.06 per share. This action raises approximately Rs 13.91 crore, representing about 9.1% of the company's current market capitalization of Rs 152 crore. The board also approved the unaudited financial results for the quarter ended June 30, 2026. This capital infusion comes at a time when the company is facing significant financial stress, with a TTM loss of Rs 87 crore and debt of Rs 113 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has increased its equity base by 6.75 crore shares through a preferential allotment, resulting in a capital infusion of ~Rs 13.91 crore.
ஏன் இது முக்கியம்The fundraise provides a small liquidity buffer for a company struggling with heavy losses and high debt, though the amount is small compared to the Rs 113 crore debt burden. The issuance at Rs 2.06 represents a discount to the current market price of Rs 3.0, leading to equity dilution.
Shares Allotted: 6,75,00,000Issue Price: Rs 2.06Fundraise Value: Rs 13.91 கோடிFundraise vs Market Cap: ~9.1%New Paid-up Capital: Rs 303.22 கோடி
📅 குறுகிய காலம்The market may react to the equity dilution and the fact that the issue price (Rs 2.06) is significantly lower than the current market price (Rs 3.0).
📈 நீண்ட காலம்The company's long-term viability depends on restarting its 6,000 TPA PAP plant and overcoming Chinese dumping pressures; this small fundraise does not fundamentally alter the structural challenges.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution
Persistent net losses (Rs -87 Cr TTM)
High debt-to-revenue ratio
Issue price below current market price
👀 கவனிக்க வேண்டியவை
Investors should closely examine the detailed Q1 FY27 financial statements to check for any recovery in operating margins, which were -107.4% in the previous trailing twelve months. Monitor the utilization of the Rs 13.91 crore proceeds to see if it is directed toward debt reduction or working capital for the non-operational PAP plant.
Sadhana Nitrochem has received in-principle approval from both BSE and NSE for a preferential issue of 6,75,00,000 equity shares of Re. 1/- each. This fundraise comes at a critical time as the company reported a TTM net loss of Rs 87 crore and negative operating margins of -107.4%. The equity infusion is likely intended to bolster liquidity or address the company's Rs 113 crore debt, given that its 6,000 TPA PAP plant remained non-operational in H2FY25 due to market conditions.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has cleared the regulatory hurdle of obtaining stock exchange approval to proceed with a significant equity issuance.
ஏன் இது முக்கியம்This fundraise is essential for the company's survival and potential turnaround, as it provides necessary capital to manage debt and potentially restart idle manufacturing capacities amid intense Chinese competition.
Shares to be issued: 6,75,00,000Face Value: Re. 1/-TTM Net Profit: Rs -87 CrTotal Debt: Rs 113 கோடிசந்தை மதிப்பு: Rs 134 கோடி
📅 குறுகிய காலம்The approval is a positive sentiment driver as it validates the company's ability to raise capital despite recent heavy losses. Expect focus on the upcoming allotment date.
📈 நீண்ட காலம்The long-term impact depends on whether the capital is used to pivot toward high-margin products like ODB2 or to sustain the PAP segment against Chinese dumping. Significant dilution is a structural concern for minority shareholders.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution
Operational losses (TTM PAT Rs -87 Cr)
High debt-to-revenue ratio
Intense competition from Chinese imports
👀 கவனிக்க வேண்டியவை
Investors should monitor the announcement of the final issue price and the identity of the allottees to understand the extent of equity dilution and promoter commitment. The key execution milestone will be the restart of the 6,000 TPA PAP plant using these funds.
Sadhana Nitrochem Reports Q1 FY26 Net Loss of ₹1.7 Cr; Divests Subsidiary and CFO Resigns
Sadhana Nitrochem Limited (SADHNANIQ) reported a net loss of ₹1.70 crore for the quarter ended June 30, 2025, compared to a profit of ₹3.99 crore in the preceding quarter. Revenue from operations declined to ₹28.10 crore from ₹40.07 crore in Q4 FY25. The company also announced the divestment of its entire stake in subsidiary Calchem Industries and the resignation of its CFO, Rakesh R. Kothari. To mitigate financial strain, executive directors waived 55% of their remuneration, totaling ₹69 lakhs.
முக்கிய அம்சங்கள்
Revenue from operations fell to ₹2,810 lakhs in Q1 FY26 from ₹3,084 lakhs in the same quarter last year.Reported a net loss of ₹170 lakhs against a marginal profit of ₹4 lakhs in Q1 FY25.Divested 100% stake in wholly-owned subsidiary Calchem Industries (India) Limited on May 28, 2025.CFO Rakesh R. Kothari resigned effective August 14, 2025, replaced by new leadership in Finance and Operations.Executive Directors waived ₹69 lakhs in remuneration to support the company's financial position.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company has swung into a loss and is undergoing significant management and structural changes. Monitor the performance of the new management team and the impact of the subsidiary divestment on future cash flows.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Sadhana Nitrochem to Issue 6.75 Crore Equity Shares at ₹2.06 via Preferential Allotment
Sadhana Nitrochem Limited has finalized the pricing for its preferential allotment of 6,75,00,000 equity shares. Following consultation with the National Stock Exchange, the floor price was determined to be ₹2.05 based on the 90-day volume-weighted average price (VWAP). The company has confirmed it will proceed with an allotment price of ₹2.06 per share, which is slightly above the regulatory floor. This move marks a significant equity issuance to raise capital for the company's operations or expansion.
முக்கிய அம்சங்கள்
Issue and allotment of 6,75,00,000 equity shares with a face value of Re. 1 each.Allotment price fixed at ₹2.06 per share, staying above the calculated floor price of ₹2.05.Floor price based on 90-day VWAP was ₹2.05, while the 10-day VWAP was ₹2.03.The issuance is being conducted on a preferential basis under SEBI ICDR Regulations.The pricing discovery was finalized in consultation with the National Stock Exchange of India.
👀 கவனிக்க வேண்டியவை
Investors should note the capital infusion which could support growth, but also be aware of the equity dilution resulting from the 6.75 crore new shares. Monitor the company's subsequent filings regarding the specific use of these proceeds.
Sadhana Nitrochem Bags Rs 108 Cr Long-Term Export Order from Japanese MNC
Sadhana Nitrochem Limited has entered into a significant long-term supply contract with a Japanese multinational for the export of speciality chemicals. The contract has a firm committed value of approximately Rs. 108 crores to be executed over a two-year period. This new order has propelled the company's total confirmed order book to over Rs. 200 crores. This development provides strong revenue visibility and validates the company's standing in the international speciality chemicals market.
முக்கிய அம்சங்கள்
Secured a long-term export contract worth approximately Rs. 108 crores.Contract duration is set for two years with a Japanese multinational customer.Total confirmed order book now stands at over Rs. 200 crores.The deal focuses on the international supply of speciality chemical products.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's execution capabilities and the resulting impact on quarterly revenue growth. The significant increase in the order book provides a positive outlook for the medium term.
Sadhana Nitrochem Reports Zero Deviation in Utilization of Rs 263.53 Cr Rights Issue Proceeds
Sadhana Nitrochem Limited has confirmed that there is no deviation or variation in the utilization of the Rs 263.53 Crores raised through its Rights Issue in March 2026. As of the quarter ended March 31, 2026, the company has already utilized Rs 251.95 Crores towards its stated objectives. Significant portions of the funds were deployed for Inter-Corporate Deposits (Rs 129.09 Cr) and Promoters Loans (Rs 80.76 Cr). The monitoring agency, Acuite Ratings and Research Limited, and the company's Audit Committee have reviewed and verified these disbursements.
முக்கிய அம்சங்கள்
Successfully raised Rs 263.53 Crores through a Rights Issue completed on March 12, 2026.Utilized Rs 251.95 Crores (approximately 95.6% of proceeds) by March 31, 2026.Allocated Rs 129.09 Crores for Inter-Corporate Deposits and Rs 80.76 Crores for Promoters Loans.Confirmed zero deviation from the original objects of the issue as per SEBI Regulation 32.Monitoring agency Acuite Ratings and Research Limited oversaw the fund utilization process.
👀 கவனிக்க வேண்டியவை
Investors should take confidence in the management's transparency and rapid deployment of capital as per the stated prospectus. No further action is required as the company is in full compliance with regulatory fund-use disclosures.
Sadhana Nitrochem FY26 Results: No Dividend Declared, ₹251.95 Cr Rights Issue Proceeds Utilized
Sadhana Nitrochem approved its audited financial results for FY26, receiving an unmodified opinion from statutory auditors. The board opted not to recommend a dividend for the year, focusing instead on operational execution and capital deployment. A key update was the confirmation that ₹251.95 crores from the recent Rights Issue have been fully utilized for their intended purposes as of March 31, 2026. The company also strengthened its governance by appointing new Internal and Cost Auditors and adding the CFO to the Risk Management Committee.
முக்கிய அம்சங்கள்
Audited FY26 financial results approved with an unmodified audit opinion from M/s. Jayesh Dadia & Associates LLP.Board recommended no dividend for the financial year 2025-26.Confirmed utilization of ₹251.95 crores in Rights Issue proceeds for specified objects till March 31, 2026.Appointed M/s. Chandrashekhar Iyer & Co as Internal Auditor and M/s. Vinay Mulay & Co as Cost Auditor for FY27.CFO Vimal R. Jain inducted into the Risk Management Committee to enhance oversight.
👀 கவனிக்க வேண்டியவை
Investors should analyze the full financial report to evaluate the ROI generated from the ₹251.95 crore capital deployment. The decision to skip dividends suggests a priority on reinvestment or liquidity preservation which warrants a closer look at the cash flow statement.
Sadhana Nitrochem Shareholders Approve Preferential Allotment and Capital Increase at EGM
Sadhana Nitrochem Limited (SADHNANIQ) held an Extraordinary General Meeting on May 22, 2026, where shareholders approved several critical resolutions. Key approvals include the issuance of equity shares via preferential allotment to private investors and an increase in the company's authorized share capital. Shareholders also cleared the appointment of Mrs. Sindhu Suneer Kotian as an Independent Director and the continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond the age of 70. All resolutions were passed with significant majorities, indicating strong shareholder support for the management's growth and capital-raising plans.
முக்கிய அம்சங்கள்
Preferential allotment of equity shares to private investors approved with 99.78% votes in favour.Increase in Authorised Share Capital and consequent MOA alteration passed with 99.73% majority.Continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond age 70 approved with 88.69% support.Total voting participation represented approximately 62.63% of the total outstanding shares for most resolutions.Appointment of Mrs. Sindhu Suneer Kotian as Non-Executive Independent Director secured 99.73% approval.
👀 கவனிக்க வேண்டியவை
Investors should monitor the specific pricing and identity of the private investors in the preferential allotment to assess potential equity dilution. The approval for capital expansion suggests the company is positioning itself for significant future growth or debt restructuring.
Sadhana Nitrochem Issues Corrigendum for EGM; Preferential Allotment Price Fixed at ₹2.06
Sadhana Nitrochem Limited has issued a corrigendum to its EGM notice regarding a preferential allotment of equity shares. The floor price for the issue has been determined at ₹2.0272 per share based on SEBI ICDR regulations, while the actual allotment price is set at ₹2.06 per share. The company clarified that Mr. Niraj Bajaj's pre-preferential holding is 14.75 crore shares (4.98%), which will increase to 20 crore shares (6.60%) post-allotment. Another investor, Poorvi Milan Chitalia, is set to invest ₹3.09 crore for a 0.49% stake.
முக்கிய அம்சங்கள்
Preferential allotment price fixed at ₹2.06 per equity share, higher than the SEBI floor price of ₹2.0272Mr. Niraj Bajaj to increase stake from 4.98% (14.75 crore shares) to 6.60% (20 crore shares) with an investment of ₹10.815 crorePoorvi Milan Chitalia to invest ₹3.09 crore for a post-allotment stake of 0.49%The 10-day Volume Weighted Average Price (VWAP) was calculated at ₹2.0272, while the 90-day VWAP was ₹1.7894Extra-Ordinary General Meeting (EGM) to be held on May 22, 2026, via video conferencing
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the EGM on May 22, as the successful completion of this preferential allotment will provide fresh capital and increase the stake of a key investor.
Sadhana Nitrochem to Raise ₹13.9 Cr via Preferential Issue; EGM Scheduled for May 22
Sadhana Nitrochem Limited has scheduled an Extraordinary General Meeting (EGM) on May 22, 2026, to seek approval for a preferential allotment of 6.75 crore equity shares. The company aims to raise approximately ₹13.905 crore by issuing shares at ₹2.06 each to private investors Niraj Bajaj and Poorvi Milan Chitalia. Other key agenda items include increasing the authorized share capital to ₹305 crore and the continuation of Mr. Asit Javeri as Executive Director beyond the age of 70. This capital infusion and leadership continuity are central to the company's immediate strategic plans.
முக்கிய அம்சங்கள்
Preferential allotment of 6,75,00,000 equity shares at ₹2.06 per share to raise ₹13.905 crore.Lead investor Niraj Bajaj to be allotted 5,25,00,000 shares, representing the bulk of the issue.Proposal to increase Authorized Share Capital from ₹300 crore to ₹305 crore.EGM to be held via Video Conferencing on May 22, 2026, with a cut-off date of May 15 for voting eligibility.Special resolution for the continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond age 70.
👀 கவனிக்க வேண்டியவை
Investors should note the equity dilution resulting from the 6.75 crore new shares but view the entry of a strategic investor like Niraj Bajaj as a positive endorsement. Monitor the company's subsequent disclosures regarding the specific utilization of these funds for growth or debt reduction.
Sadhana Nitrochem to Raise ₹13.91 Crore via Preferential Allotment; Increases Authorized Capital
Sadhana Nitrochem's board has approved a preferential allotment of 6.75 crore equity shares at ₹2.06 each to raise approximately ₹13.91 crore for working capital needs. A key highlight is the increased participation of investor Niraj Bajaj, whose stake will rise from 4.98% to 6.60% post-allotment. The company is also increasing its authorized share capital from ₹300 crore to ₹305 crore to accommodate this issuance. An Extraordinary General Meeting (EGM) is scheduled for May 22, 2026, to obtain shareholder approval for these corporate actions.
முக்கிய அம்சங்கள்
Approved preferential allotment of 6,75,00,000 equity shares at an issue price of ₹2.06 per share.Total fundraise of approximately ₹13.91 crore intended for working capital support.Investor Niraj Bajaj to increase his shareholding from 4.98% to 6.60% post-issue.Authorized share capital increased from ₹300 crore to ₹305 crore.Extraordinary General Meeting (EGM) convened for May 22, 2026, to finalize approvals.
👀 கவனிக்க வேண்டியவை
Investors should view the stake increase by a prominent investor as a sign of confidence, though they should monitor the company's ability to improve margins with the additional working capital. Keep an eye on the EGM results on May 22 for final confirmation of the allotment terms.
Sadhana Nitrochem Receives Trading Approval for 263.52 Crore Rights Issue Shares
Sadhana Nitrochem Limited has secured final trading approval from both BSE and NSE for 2,63,52,83,328 equity shares issued via its recent Rights Issue. These shares, with a face value of Re. 1 each, were issued at par and will be admitted for trading effective March 17, 2026. This marks the completion of a massive equity expansion, which will significantly increase the company's total share capital and liquidity in the market.
முக்கிய அம்சங்கள்
Trading approval received for 2,63,52,83,328 equity shares of Re. 1/- each.New shares were issued at par (Re. 1) on a rights basis.Trading of the new shares is scheduled to commence on March 17, 2026.Approval letters received from BSE (LOD/RIGHTS/SV/69/2025-2026) and NSE (NSE/LIST/2026/54054).
👀 கவனிக்க வேண்டியவை
Investors should be cautious as the massive influx of over 263 crore new shares may lead to significant equity dilution and short-term price volatility. Monitor how the company utilizes the raised capital to drive future earnings growth to offset the dilution.
Sadhana Nitrochem Allots 263.5 Crore Equity Shares via Rights Issue at ₹1 Each
Sadhana Nitrochem Limited has successfully completed the allotment of 263,52,83,328 equity shares following its Rights Issue. The shares were issued at a price of ₹1 per equity share, significantly expanding the company's equity base. As a result, the paid-up equity share capital has increased from ₹32.94 crore to ₹296.47 crore. While 5,128 shares are kept in abeyance pending clearances, the new shares will rank pari-passu with existing equity.
முக்கிய அம்சங்கள்
Allotment of 263,52,83,328 fully paid-up equity shares at an issue price of ₹1 per sharePaid-up equity share capital increased from ₹32,94,11,057 to ₹2,96,46,94,3855,128 Rights Equity Shares kept in abeyance pending regulatory or other clearancesNew shares rank pari-passu in all respects with existing fully paid-up equity shares
👀 கவனிக்க வேண்டியவை
Investors should be aware of the significant equity dilution as the share capital has increased nearly nine-fold. Monitor the company's utilization of these funds and the subsequent impact on Earnings Per Share (EPS).
Sadhana Nitrochem Sets February 19, 2026, as Record Date for Rights Issue
Sadhana Nitrochem Limited has officially designated February 19, 2026, as the record date for its upcoming Rights Issue. This date is crucial as it determines which shareholders are eligible to receive Rights Entitlements (REs) in their demat accounts. The company is proceeding with this capital raising activity in compliance with SEBI Listing and Disclosure requirements. Investors must hold the shares on or before this date to participate in the offering.
முக்கிய அம்சங்கள்
The official record date for the Rights Issue is fixed for February 19, 2026.The purpose is to identify shareholders eligible for Rights Entitlements under the proposed issue.The announcement follows compliance with Regulation 42 of SEBI LODR and Regulation 68 of SEBI ICDR.The ISIN for the Rights Entitlement is identified as INE888C20024.
👀 கவனிக்க வேண்டியவை
Existing shareholders should check the rights price and ratio once announced to decide on exercising their rights. Those wishing to participate must ensure they hold the shares by the record date to receive entitlements.
Sadhana Nitrochem Approves ₹263.53 Crore Rights Issue with 8:1 Ratio
Sadhana Nitrochem Limited has finalized the terms for a significant rights issue totaling ₹263.53 crore. The company will issue 263.53 crore new equity shares at a price of Re. 1 per share, which is at par with the face value. Existing shareholders are entitled to 8 new shares for every 1 share held as of the record date. The record date for this corporate action is set for February 19, 2026.
முக்கிய அம்சங்கள்
Total rights issue size fixed at ₹26,352.92 lakhs (approximately ₹263.53 crore)Rights entitlement ratio set at 8 fully paid-up equity shares for every 1 share heldIssue price determined at Re. 1 per share, representing zero premium over face valueRecord date for eligibility established as February 19, 2026Total number of fresh rights shares to be issued is 263,52,92,056
👀 கவனிக்க வேண்டியவை
Investors should be aware of the massive equity dilution resulting from the 8:1 ratio and decide whether to subscribe to maintain their ownership percentage. Monitor the stock price closely as it will likely adjust significantly on the ex-rights date.
Sadhana Nitrochem Q3 Results: Revenue Drops 81% YoY to ₹5.66 Cr; Posts ₹25.4 Cr Net Loss
Sadhana Nitrochem reported a dismal set of numbers for Q3 FY26, with revenue from operations crashing 81% YoY to ₹5.66 crore. The company swung to a net loss of ₹25.40 crore from a profit of ₹0.64 crore in the previous year's corresponding quarter. Management highlighted technical constraints, liquidity challenges, and US tariff-related trade uncertainties as the primary drivers for this downturn. For the nine-month period, the company has accumulated a net loss of ₹53.48 crore, significantly impacting its financial health.
முக்கிய அம்சங்கள்
Quarterly revenue from operations plummeted to ₹566.26 lakhs from ₹2,975 lakhs YoY.Net loss for Q3 FY26 widened to ₹2,540 lakhs compared to a profit of ₹64 lakhs in Q3 FY25.Finance costs rose to ₹688 lakhs from ₹464 lakhs YoY, reflecting increased debt servicing pressure.Total comprehensive loss for the nine-month period ended Dec 2025 stood at ₹5,361 lakhs.Management cited US tariff uncertainties and technical production constraints as primary reasons for the decline.
👀 கவனிக்க வேண்டியவை
The sharp decline in revenue and mounting losses suggest significant operational and external headwinds. Investors should remain cautious and monitor the promised Q4 recovery closely before making new commitments.
Sadhana Nitrochem: Postal Ballot for Director Appointment
Sadhana Nitrochem Limited is seeking shareholder approval via postal ballot for the appointment of Mr. Tej Mayur Contractor (DIN: 00454197) as a Non-Executive Independent Director. The appointment is for a term of 5 years, commencing from October 18, 2025, up to October 17, 2030. The e-voting period will commence on December 17, 2025, at 9:00 A.M. (IST) and conclude on January 15, 2026, at 5:00 P.M. (IST). The results will be declared on or before January 17, 2026.
முக்கிய அம்சங்கள்
Appointment of Mr. Tej Mayur Contractor (DIN: 00454197) as Non-Executive Independent Director.Director term: 5 years, from October 18, 2025 to October 17, 2030.E-voting starts December 17, 2025, at 9:00 A.M. (IST).E-voting ends January 15, 2026, at 5:00 P.M. (IST).
👀 கவனிக்க வேண்டியவை
Shareholders should review the postal ballot notice and cast their votes electronically between December 17, 2025, and January 15, 2026. Ensure your email address is registered with the company/depositories to receive the notice and e-voting details.
Sadhana Nitrochem appoints Tej Mayur Contractor as Non-Executive Independent Director
Sadhana Nitrochem Limited announced the appointment of Mr. Tej Mayur Contractor (DIN: 00454197) as a Non-Executive Independent Director. The board also approved a draft postal ballot notice for shareholder consent. The company will utilize NSDL's e-voting platform for the postal ballot and has appointed a scrutinizer to oversee the voting process. These decisions were made via circular resolution on December 12, 2025.
முக்கிய அம்சங்கள்
Appointment of Mr. Tej Mayur Contractor (DIN: 00454197) as Non–Executive Independent DirectorCompany to avail services of NSDL for e-voting platform for the Postal BallotAppointment of Scrutiniser to scrutinise voting process for the Postal Ballot
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming postal ballot for any significant proposals requiring shareholder approval. Review Mr. Contractor's background and qualifications to assess his potential impact on the company.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
